FDA
-
-
-
-
-
-
-
CVRx Reports First Quarter 2026 Financial and Operating Results
-
-
-
-
-
-
-
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
-
-
-
-
-
-
-
CVRx receives Category I CPT codes for Barostim heart failure therapy
-
-
-
-
-
-
-
CVRx Reports Second Quarter 2025 Financial and Operating Results
-
-
-
-
-
-
-
CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025
-
-
-
-
-
-
-
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

